Literature DB >> 15271431

Equine recurrent uveitis: new methods of management.

Brian C Gilger1, Tammy Miller Michau.   

Abstract

Equine recurrent uveitis (ERU) is one of the most common causes of blindness in horses. Until recently, treatment of this condition consisted only of symptomatic therapy, typically with steroidal and nonsteroidal medications. A better understanding of the disease process(es) has permitted new medical and surgical therapies that have recently been described. This article highlights clinical features of ERU, the causes of ERU, and new management and treatment options for horses with ERU.

Entities:  

Mesh:

Year:  2004        PMID: 15271431     DOI: 10.1016/j.cveq.2004.04.010

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  9 in total

1.  Diagnostic ophthalmology. Anterior uveitis of the right eye.

Authors:  Lynne S Sandmeyer; Bianca S Bauer; Bruce H Grahn
Journal:  Can Vet J       Date:  2013-09       Impact factor: 1.008

2.  LruA and LruB, novel lipoproteins of pathogenic Leptospira interrogans associated with equine recurrent uveitis.

Authors:  Ashutosh Verma; Sergey Artiushin; James Matsunaga; David A Haake; John F Timoney
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

3.  Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide.

Authors:  Caryn E Plummer; Timothy Polk; Jatin Sharma; Sanghyo Sarah Bae; Olivia Barr; Amari Jones; Holly Kitchen; Michelle Wilhelmy; K Devin; W Clay Smith; Bryan D Kolaczkowski; Joseph Larkin
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

4.  Cross-reactivity of antibodies against leptospiral recurrent uveitis-associated proteins A and B (LruA and LruB) with eye proteins.

Authors:  Ashutosh Verma; Pawan Kumar; Kelly Babb; John F Timoney; Brian Stevenson
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

5.  Unraveling the equine lymphocyte proteome: differential septin 7 expression associates with immune cells in equine recurrent uveitis.

Authors:  Roxane L Degroote; Stefanie M Hauck; Barbara Amann; Sieglinde Hirmer; Marius Ueffing; Cornelia A Deeg
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

6.  Interaction of septin 7 and DOCK8 in equine lymphocytes reveals novel insights into signaling pathways associated with autoimmunity.

Authors:  Melanie Schauer; Kristina J H Kleinwort; Roxane L Degroote; Carmen Wiedemann; Elisabeth Kremmer; Stefanie M Hauck; Cornelia A Deeg
Journal:  Sci Rep       Date:  2018-08-17       Impact factor: 4.379

Review 7.  The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses.

Authors:  Elizabeth S MacDonald; Jennifer G Barrett
Journal:  Front Vet Sci       Date:  2020-01-21

8.  Pre-Activated Granulocytes from an Autoimmune Uveitis Model Show Divergent Pathway Activation Profiles upon IL8 Stimulation In Vitro.

Authors:  Anne L C Hoffmann; Stefanie M Hauck; Cornelia A Deeg; Roxane L Degroote
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

9.  Penetration of topically administered dexamethasone disodium phosphate and prednisolone acetate into the normal equine ocular fluids.

Authors:  Hanneke Hermans; Els M H van den Berg; Inge J M Slenter; Dax J C Vendrig; Lilian J L de Nijs-Tjon; Johannes C M Vernooij; Harold Brommer; Michael H Boevé; Ronette Gehring
Journal:  Equine Vet J       Date:  2021-11-21       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.